-+ 0.00%
-+ 0.00%
-+ 0.00%

PDS Biotechnology Q3 EPS $(0.11) Misses $(0.09) Estimate

Benzinga·11/13/2026 13:14:13
Listen to the news
PDS Biotechnology (NASDAQ:PDSB) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.09) by 22.22 percent. This is a 42.11 percent increase over losses of $(0.19) per share from the same period last year.